Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2005
07/13/2005CN1210400C Methods for making proteins contaniing free cysteine residues
07/13/2005CN1210309C Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them
07/12/2005US6916917 Chimeric pro-caspases and methods of using same
07/12/2005US6916916 Chinese hamster ovaries defective in expression of neuramidase activity for producing glycoproteins with intact carbohydrate chains; antisense agents
07/12/2005US6916914 Extracting and isolating hormone polypeptide from escherichia using xylene and/or tolulene; gene therapy
07/12/2005US6916913 Dorsalin-1 polypeptide and uses thereof
07/12/2005US6916907 Comprises osteoclastogenesis inhibitory factor (OCIF) polypeptide for diagnosis and treatment of bone disorders
07/12/2005US6916782 Gene coding for heliomicine and use thereof
07/12/2005US6916648 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/12/2005US6916644 Genetic engineered protein; controlling cell proliferation, cell differentiation
07/12/2005US6916631 Comprises monoclonal antibody for diagnosis and treatment of skin disorders
07/12/2005US6916629 Tissue factor pathway inhibitor-3
07/12/2005US6916625 Artery- and vein-specific proteins and uses therefor
07/12/2005US6916624 Antibody for use in the diagnosis and treatment of cancer
07/12/2005US6916623 Generation of soluble protein; obtain vector, incubate with nucleotide sequnces coding protein domains, digest sequences, ligate, express vector in cell free system, recover protein
07/12/2005US6916615 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof
07/12/2005US6916607 Gene controlling androgen
07/12/2005US6916475 Anti-idiotypic antibody and its use in regulating the composition of T cell lymphocytes
07/12/2005CA2264275C Monoclonal antibody specific to an anti-human fibrin monomer, method for producing the monoclonal antibody, hybridoma, and immunoassay
07/12/2005CA2222718C Attachment enhanced 293 cells
07/12/2005CA2201419C Human t-cell lymphotropic virus type i envelope protein and human monoclonal antibodies specific therefor
07/12/2005CA1341485C Fusion proteins utilizing the decay accelerating factor membrane binding domain
07/07/2005WO2005061703A1 Gene amplification method
07/07/2005WO2005061541A1 Anti-igf-i receptor antibody
07/07/2005WO2005023979A3 Isolated s. mansoni nucleic acid molecules and uses thereof
07/07/2005WO2004085666A3 Secreted proteins
07/07/2005WO2004050849A8 Recombinant immunotoxin and use in treating tumors
07/07/2005US20050150011 Viral amplification of recombinant messenger RNA in transgenic plants
07/07/2005US20050148761 Genetic products of ashbya gossypii, associated with transmembrane transport
07/07/2005US20050148619 Sulfonamido ether substituted imidazoquinolines
07/07/2005US20050148058 Protein stabilization
07/07/2005US20050148049 Proteolytic fermenter
07/07/2005US20050148048 Process for producing dipeptides
07/07/2005US20050148046 Reaction solution for cell-free protein synthesis, method of preparing the same, and protein synthesis method using the same
07/07/2005US20050148039 Process and materials for the rapid detection of Streptococcus pneumoniae employing purified antigen-specific antibodies
07/07/2005US20050148035 fusion proteins comprising insulin-like growth factor binding protein-3 fragments of human native-sequence, linked to a synthetic polypetide, used in cell-based assays, as IGF antagonists, in mapping IGF binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides
07/07/2005US20050148014 Regulation of human P2Y1-like G protein-coupled receptor
07/07/2005US20050148012 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
07/07/2005US20050147993 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector
07/07/2005US20050147988 Recombinant protein for use as tool in detection of helicobacter infection; immunodiagnostics
07/07/2005US20050147971 Biomolecule transduction motif mph-1-btm and the use thereof
07/07/2005US20050147969 Genes associated with mast cell activation
07/07/2005US20050147618 comprising blood coagulation factors and segments of an immunoglobulin fragments, used for treating hemostatic disorders
07/07/2005US20050147616 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
07/07/2005US20050147610 Polypeptides comprising antigen binding domains for diagnosis, prevention and treatment of inflammation, skin, respiratory, kidney, cardiovascular, nervous system and pancreatic disorder
07/07/2005US20050147590 Immunogenic minicells and methods of use
07/07/2005CA2546502A1 A method for gene amplification
07/06/2005EP1550729A1 Target binding polypeptide comprising an IG-like VL domain linked to an IG-like VH domain
07/06/2005EP1550728A1 Lyophilized preparation for synthesis of cell-free protein
07/06/2005EP1550720A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof
07/06/2005EP1549762A1 Methods for the enrichment of low-abundance polynucleotides
07/06/2005EP1549757A1 Method of purifying lantibiotics
07/06/2005EP1549746A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins
07/06/2005EP1549671A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/06/2005EP1549666A1 Process for the purification of recombinant proteins from complex media and purified proteins obtained thereby
07/06/2005EP1549342A2 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
07/06/2005EP1549341A2 Novel tissue factor targeted antibodies as anticoagulants
07/06/2005EP1468079A4 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same
07/06/2005EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
07/06/2005EP0730651B1 Surface loop structural analogues of fibroblast growth factors
07/06/2005CN1636070A Nucleic acid encoding a G-protein-coupled receptor, and uses thereof
07/06/2005CN1636067A TACIs and BR3 polypeptides and uses thereof
07/06/2005CN1636060A Methods of delivery of exogenous proteins to the cytosol and uses thereof
07/06/2005CN1636056A Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
07/06/2005CN1636016A Methods to inhibit viral replication
07/06/2005CN1636012A Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
07/06/2005CN1635988A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
07/06/2005CN1635901A Remodeling and glycoconjugation of peptides
07/06/2005CN1635896A Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
07/06/2005CN1635138A Fermentation method of small peptide natural microbiological antiseptic
07/06/2005CN1635137A Process for preparing soybean antioxidant peptides
07/06/2005CN1635136A Method for preparing plant separated protein
07/06/2005CN1635135A Process for preparing microbiological protein from alcohol supernatant
07/06/2005CN1635110A Space mutagenesis high production and highly performance bacterial and use thereof
07/06/2005CN1635071A Hygienic beer containing casein phospho-peptides and its prepration
07/06/2005CN1634982A A portion of extracellular domain peptide segment of eukaryotic cells secretion expressed carcinembryonic antigen
07/06/2005CN1634962A Process for preparing synergy factor in artificial blood, nucleotide sequence used thereby
07/06/2005CN1209465C Method for producing collagen oligopeptide
07/06/2005CN1209374C Human Protein for promoting transform of 3T3 cell and its coding sequence
07/06/2005CN1209373C Human protein with suppression to cancer cell growth and its coding sequence
07/06/2005CN1209370C New human protein with cancer inhibiting function and its encoding sequence
07/06/2005CN1209369C Cell death inducing protein and its coding sequence and use
07/05/2005US6914125 Scramblase 2
07/05/2005US6914043 Frozen food products comprising anti-freeze protein (AFP) type III HPLC 12
07/05/2005US6913924 Population of interferon producing cells
07/05/2005US6913916 Elongase genes and uses thereof
07/05/2005US6913907 Enterococcus faecalis polynucleotides encoding EF059
07/05/2005US6913892 Method of obtaining compositions comprising Y4 specific compounds
07/05/2005US6913752 Characterized by the loss of its capability to reproductively replicate in human cell lines.
07/05/2005US6913749 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies
07/05/2005CA2419492C Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore
07/05/2005CA2280875C Remedies for lymphocytic tumors
07/05/2005CA2215793C Use of neuronal apoptosis inhibitor protein (naip)
07/05/2005CA2129663C Biosynthetic binding protein for cancer marker
06/2005
06/30/2005WO2005059131A2 Protein binding miniature proteins and uses thereof
06/30/2005WO2005059127A1 Processing of peptides and proteins
06/30/2005WO2005058963A1 Anti-hiv antibody
06/30/2005WO2005058957A2 Ztnf 12, a tumor necrosis factor
06/30/2005WO2005058952A2 Ztnf13, a tumor necrosis factor
06/30/2005WO2005058951A1 Sugar chain-lacking hepatocyte growth factor